๐ฌDeep Research
BIOA โ BioAge Labs Inc ยท catalysts, narrative & risks
BioAge Labs (BIOA) โ Point-in-Time Snapshot
BioAge Labs, Inc. trades on the NASDAQ under ticker BIOA and is a clinical-stage biopharmaceutical company developing therapeutic candidates for cardiometabolic diseases by targeting the biology of human aging. Its lead candidate, BGE-102, is an oral, brain-penetrant small-molecule NLRP3 inhibitor [2][7][8][14].
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ